Sign In
Buy ESSA
$20.61
+0 (+0%)
At Close: Oct 23, 2025
ESSA Announces Completion of Arrangement with XenoTherapeutics
07:00am, Thursday, 09'th Oct 2025
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada , Oct. 9, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherapeutics'
ESSA Securityholders Approve Acquisition by XenoTherapeutics
05:14pm, Monday, 06'th Oct 2025
SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada , Oct. 6, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") is pleased to announce that its Securityholders (as defined bel
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
04:30pm, Tuesday, 30'th Sep 2025
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , Sept.
K12 Tutoring Strengthens ESSA Validation with New Multi-Grade Results
12:00pm, Monday, 29'th Sep 2025
RESTON, VA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- K12 Tutoring, part of the Stride, Inc. (NYSE: LRN) portfolio, has once again been validated under the Every Student Succeeds Act (ESSA) Level II standard
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
06:00am, Wednesday, 24'th Sep 2025
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised terms Further Adjourns Special Meeting to October
CNB Financial Corporation Completes Merger with ESSA Bancorp, Inc.
08:00am, Thursday, 24'th Jul 2025
CLEARFIELD, Pa., July 24, 2025 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“CNB” or the “Company”) (NASDAQ: CCNE) announced that it completed the merger (“Merger”) of ESSA Bancorp, Inc
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , July 23, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that, in connection with its previously announ
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC and BOSTON and EMERYVILLE, Calif.
CNB Financial Corporation and ESSA Bancorp, Inc. Receive Bank Regulatory Approvals for Merger
04:15pm, Monday, 30'th Jun 2025
CLEARFIELD, PA and STROUDSBURG, PA / ACCESS Newswire / June 30, 2025 / CNB Financial Corporation ("CNB") (NASDAQ:CCNE) and ESSA Bancorp Inc. ("ESSA") (NASDAQ:ESSA) are pleased to announce that they ha
CNB Financial Corporation and ESSA Bancorp, Inc. Receive Bank Regulatory Approvals for Merger
04:05pm, Monday, 30'th Jun 2025
CLEARFIELD, Pa. and STROUDSBURG, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“CNB”) (NASDAQ: CCNE) and ESSA Bancorp Inc. (“ESSA”) (NASDAQ: ESSA) are pleased to announce
ESSA Bancorp, Inc. Declares Quarterly Dividend
04:35pm, Wednesday, 21'st May 2025
STROUDSBURG, PA / ACCESS Newswire / May 21, 2025 / ESSA Bancorp, Inc. (NASDAQ Global MarketSM:ESSA), the holding company for ESSA Bank & Trust, today announced that its Board of Directors declared a d
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025
07:00am, Thursday, 08'th May 2025
Company continues to explore and review strategic options focused on maximizing shareholder value SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , May 8, 2025 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," o
K12 Tutoring Earns ESSA Level II Validation, Confirming Impact on Student Achievement
10:00am, Wednesday, 30'th Apr 2025
An independently validated study highlighted K12 Tutoring's success in personalized, academic support An independently validated study highlighted K12 Tutoring's success in personalized, academic supp
ESSA Bancorp, Inc. Announces Fiscal Second Quarter and Fiscal First Half 2025 Financial Results
04:35pm, Wednesday, 23'rd Apr 2025
STROUDSBURG, PA / ACCESS Newswire / April 23, 2025 / ESSA Bancorp, Inc. (the "Company") (NASDAQ:ESSA), the holding company for ESSA Bank & Trust (the "Bank"), a $2.2 billion asset financial institutio
CLEARFIELD, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“CNB”) (NASDAQ: CCNE) is pleased to announce that leading independent proxy advisory firm Institutional Shareholder
